Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,568 total articles
Aramark reported a modest Q1 beat and reiterated full-year guidance while showing strong new-business momentum and record client retention. Valuation is reasonable on an EV/sales basis but P/E is elevated; balance sheet leverage is meaningful. We initiate a tactical long trade that targets a re-rating as Nexus and digital services lift organic grow…
Pony AI trades like a beaten-down leader in China’s robotaxi race. With a $3.04B market cap, an oversold technical setup (RSI ~30), and visible commercial traction (Zagreb launch, Q4 revenue $29.1M), the risk-reward favors a tactical long. This trade targets $10.50 over ~45 trading days, with a hard stop at $6.10.
Bumble's AI push and improved EBITDA picture have turned a deteriorating user story into a conditional recovery. The shares trade near multi-year lows and carry a compelling valuation if the AI-driven product improvements scale; however, elevated leverage, choppy user trends and ongoing legal/noise risks make this a speculative hold rather than a b…
Tractor Supply (TSCO) screens inexpensive relative to recent history: market cap ~$16.4B, P/E ~15, and a 3% yield. Q1 weakness concentrated in pet food and traffic pressured shares, but management reiterated guidance and the business still generates solid cash flow. For patient investors, a long entry at $31.50 with a $45 target and $27.50 stop bal…
Uber just had a meaningful pullback to the mid-$60s earlier this month, but core business momentum - 25% gross bookings growth and $13.2B in revenue last quarter - plus a healthy free cash flow profile make this a compelling buy-the-dip swing trade. Use disciplined sizing and a tight stop below the $67 low to limit downside while targeting a move b…
British American Tobacco (BTI) trades at a modest multiple, yields ~4.9%, and is positioned to benefit from rapid growth in nicotine pouches (Velo). We lay out an actionable long trade with entry, stop, and target, plus catalysts and downside scenarios.
Micron sits at the center of an AI-driven memory supercycle. With HBM scarcity, fiscal Q3 revenue of $41.46B (345% YoY), a $30B cash war chest and guidance pointing to $50B next quarter, Micron can sustain a multi-quarter re-rating. This trade targets $1,800 with a $900 stop, sized for traders who can withstand elevated cyclicality and headline ris…
AppLovin's AI-driven ad stack and recent beat-and-raise momentum set up a high-reward trade. We lay out an entry at current levels, a $710 upside target tied to multiple expansion and execution, and a disciplined stop at $425 to control downside.
Titan Mining presents a compact risk-reward: a low-market-cap zinc play that could benefit from higher zinc prices and U.S. critical-minerals policy support. This is a structured long with a clear entry, stop and target for a 180-trading-day horizon, balanced against permitting and financing risks.
Graham Holdings (GHC) is a diversified holding company trading around $1,160 with a market cap near $5.0B, P/B ~1.04 and P/E ~16.8. Strong free cash flow, low leverage, and a mix of education, healthcare and broadcasting assets make the business defensible. We present a tactical long with an entry at $1,150, stop at $1,040 and target at $1,250 over…
United Parks & Resorts (PRKS) has been punished for attendance hiccups and earnings misses, but the underlying cash generation and valuation multiples argue for a long trade. I outline an actionable plan with entry, stop and target, explain the fundamental backdrop, list catalysts, and lay out the risks that could derail the thesis.
Precision Drilling trades at a sub-1 PB, sits near oversold technicals (RSI ~31.6) and has a compact market cap of roughly $1.0B. I plan a long trade at the current price with a $97 target over 180 trading days and a $72 stop — a trade that balances upside from a potential re-rating and operational improvement against clear cyclical and execution r…
Precigen is showing the first signs of commercial scale after FDA approval of PAPZIMEOS: $21.6M in net product revenue in the first full quarter, permanent J-code reimbursement, broad payer coverage and a path to cash-flow break-even by year-end. The stock carries lofty valuation multiples, heavy short interest and an overbought technical reading, …
KULR Technology Group ($KULR) remains a compelling takeover candidate based on proprietary carbon-fiber thermal products, recent strategic collaborations, constrained market value (EV ~$170M), and a sizeable short interest that can amplify moves. This trade idea lays out an actionable long with entry, stop, and target, plus catalysts and risks to w…
MoonLake Immunotherapeutics is a clinical-stage biotech with a single major value driver: sonelokimab. With Phase 3 Week-40 results showing durable responses and management targeting a BLA submission in H2 2026, MLTX offers an asymmetric risk/reward for a disciplined long trade. The company has meaningful cash per share and an upcoming regulatory c…
Spyre Therapeutics has pivoted from single-agent binary risk toward a deliberately engineered combination strategy. Positive Phase 2 SKYLINE Part A results for SPY001, an upsized $403M financing, and a deepening commercial bench justify a mid-term long trade that targets upside toward the 52-week range while respecting biotech volatility with a tig…
Tesla's valuation still embeds moonshot expectations, but two large initiatives - Full Self-Driving/robotaxi economics and accelerating energy storage sales - are moving from theory to measurable revenue vectors. With a $1.44T market cap, $7B of free cash flow and stretched multiples, this trade targets a measured long exposure with a mid-term hori…
Sandisk's meteoric rally has grabbed headlines, but it feels closer to a speculative blowoff than a sustainable re-rating. Western Digital offers a more measured exposure to the AI-driven storage boom: strong cash generation, healthy margins, and a balance sheet that can handle normalizing memory cycles. This trade idea buys the recent WDC weakness…
Western Midstream (WES) offers an industry-leading yield (about 8.6%) backed by ~$1.34B in free cash flow, a midstream asset base tied to production growth, and valuation support near the midpoint of its 52-week range. This trade plan targets a move back to $48 while keeping a protective stop below $38.50.
Uber’s core marketplace is accelerating: gross bookings are up 25%, revenue climbed to $13.2B in the most recent quarter, and free cash flow sits near $9.1B. The market is fretting over an AI-driven capex and R&D ramp, but those investments sit on top of a highly cash-generative platform with attractive multiples. This trade idea lays out an action…
<p>Microsoft reportedly shed about $1.3 trillion in market value from its prior peak. We view a sizeable portion of that drawdown as temporary price action tied to sentiment and short-term risk-off positioning rather than a permanent impairment of fundamentals. This trade idea upgrades Microsoft to a buy and lays out a tactical long with clear entr…
Pfizer offers a rare combination today: a double-digit-ish dividend yield (above 7%), healthy free cash flow ($9.49B) and an inexpensive EV/EBITDA (~8.3x). Those attributes make a disciplined long trade attractive even as the company navigates a patent cliff and pipeline execution risk. This idea lays out an entry at $24.10, a $28 target and a $21.…
Exail Technologies is a small, specialized defense and robotics company with attractive strategic assets but thin liquidity and takeover dynamics that can cap upside. We lay out a mid-term long trade with a clearly defined stop and target, alongside the catalysts and the takeover risk that should keep position sizes conservative.
Ford's recent price swing tied to AI/energy headlines created an entry window. At $14.39, the stock trades cheaply by several valuation metrics, generates roughly $9.55B of free cash flow, and yields about 4.25% after the $0.15 quarterly dividend. This trade targets a mid-term rebound to $16.50 while limiting downside to $13.50. The thesis rests on…
Rheinmetall’s share-price weakness after recent headlines looks overdone relative to order backlog, cash generation potential, and medium-term margin normalisation. We upgrade to Strong Buy and lay out an actionable trade: entry $180.00, target $230.00, stop $150.00.
